SCHEMBL22817675

SCHEMBL22817675

c1ccc(-c2ccccc2N(c2cccc3c2oc2ccccc23)c2cccc3oc4c5ccccc5c(-c5ccc6ccccc6c5)cc4c23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.40
▸ GGPS1 O95749 1/20 0.34
▸ PRKDC P78527 2/20 0.33
▸ CYP1A1 P04798 1/20 0.33
▸ CYP1B1 Q16678 1/20 0.33
▸ PTGES2 Q9H7Z7 1/20 0.32
▸ GPR84 Q9NQS5 1/20 0.32
▸ ALDH1A1 P00352 3/20 0.31
▸ MAPT P10636 2/20 0.31
▸ CYP1A2 P05177 2/20 0.31
▸ KDM4E B2RXH2 2/20 0.31
▸ HSD17B10 Q99714 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ TP53 P04637 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22817950 0.93 ALOX5 (0.36) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22817699 0.92 ALOX5 (0.36) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22818199 0.91 ALOX5 (0.42) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22818204 0.91 ALOX5 (0.41) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22818271 0.91 ALOX5 (0.43) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22818436 0.91 ALOX5 (0.40) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22817587 0.91 ALOX5 (0.36) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22817661 0.90 ALOX5 (0.36) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22818247 0.90 ALOX5 (0.36) ALOX5GGPS1PRKDCCYP1A1CYP1B1
SCHEMBL22818164 0.89 ALOX5 (0.41) ALOX5GGPS1PRKDCCYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same LT MATERIALS CO., LTD. (KR) 2023-11-07 — — US disclosed
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LT MATERIALS CO., LTD. (KR) 2020-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11812623-B2 Hetero-cyclic compound and organic light emitting device using the same CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885PRKDC 2919/4885
US-20200403157-A1 HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, PER2 ALOX5 1385/4885GGPS1 598/4885PRKDC 2919/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback